# Dyslipidemia in Type 2 Diabetes (0767-034)

> **NCT00547274** · PHASE3 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 111 (actual)

## Conditions studied

- Diabetes Mellitus, Type II
- Dyslipidemia

## Interventions

- **DRUG:** MK0767

## Key facts

- **NCT ID:** NCT00547274
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2015-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547274, "Dyslipidemia in Type 2 Diabetes (0767-034)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00547274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*